These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18506577)

  • 21. Hologram quantitative structure-activity relationships investigations of non-nucleoside reverse transcriptase inhibitors.
    Pungpo P; Hannongbua S; Wolschann P
    Curr Med Chem; 2003 Sep; 10(17):1661-77. PubMed ID: 12871115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial neural networks: non-linear QSAR studies of HEPT derivatives as HIV-1 reverse transcriptase inhibitors.
    Douali L; Villemin D; Zyad A; Cherqaoui D
    Mol Divers; 2004; 8(1):1-8. PubMed ID: 14964783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chiral resolution, absolute configuration assignment and biological activity of racemic diarylpyrimidine CH(OH)-DAPY as potent nonnucleoside HIV-1 reverse transcriptase inhibitors.
    Gu SX; Li ZM; Ma XD; Yang SQ; He QQ; Chen FE; De Clercq E; Balzarini J; Pannecouque C
    Eur J Med Chem; 2012 Jul; 53():229-34. PubMed ID: 22575532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.
    Cichero E; Cesarini S; Spallarossa A; Mosti L; Fossa P
    J Mol Model; 2009 Jul; 15(7):871-84. PubMed ID: 19153780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.
    Cichero E; Cesarini S; Fossa P; Spallarossa A; Mosti L
    Eur J Med Chem; 2009 May; 44(5):2059-70. PubMed ID: 19046616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docking field-based QSAR and pharmacophore studies on the substituted pyrimidine derivatives targeting HIV-1 reverse transcriptase.
    Fan N; Zhang S; Sheng T; Zhao L; Liu Z; Liu J; Wang X
    Chem Biol Drug Des; 2018 Feb; 91(2):398-407. PubMed ID: 28816417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3,4,5-Trisubstituted-1,2,4-4H-triazoles as WT and Y188L mutant HIV-1 non-nucleoside reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.
    Cichero E; Buffa L; Fossa P
    J Mol Model; 2011 Jul; 17(7):1537-50. PubMed ID: 20922443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Chen X; Liu X; Meng Q; Wang D; Liu H; De Clercq E; Pannecouque C; Balzarini J; Liu X
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6593-7. PubMed ID: 24239481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear and nonlinear quantitative structure-activity relationship modeling of the HIV-1 reverse transcriptase inhibiting activities of thiocarbamates.
    Goodarzi M; Freitas MP; Vander Heyden Y
    Anal Chim Acta; 2011 Oct; 705(1-2):166-73. PubMed ID: 21962359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
    Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
    Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
    Mandal AS; Roy K
    Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docking-based CoMFA and CoMSIA studies of non-nucleoside reverse transcriptase inhibitors of the pyridinone derivative type.
    Medina-Franco JL; Rodríguez-Morales S; Juárez-Gordiano C; Hernández-Campos A; Castillo R
    J Comput Aided Mol Des; 2004 May; 18(5):345-60. PubMed ID: 15595461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
    Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
    Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
    Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
    Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative structure-activity relationships and comparative molecular field analysis of TIBO derivatised HIV-1 reverse transcriptase inhibitors.
    Hannongbua S; Pungpo P; Limtrakul J; Wolschann P
    J Comput Aided Mol Des; 1999 Nov; 13(6):563-77. PubMed ID: 10584215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monte Carlo sampling and multivariate adaptive regression splines as tools for QSAR modelling of HIV-1 reverse transcriptase inhibitors.
    Alamdari RF; Mani-Varnosfaderani A; Asadollahi-Baboli M; Khalafi-Nezhad A
    SAR QSAR Environ Res; 2012 Oct; 23(7-8):665-82. PubMed ID: 22746992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-QSAR, molecular docking, and molecular dynamics simulation of a novel thieno[3,4-d]pyrimidine inhibitor targeting human immunodeficiency virus type 1 reverse transcriptase.
    Chu H; He QX; Wang JW; Deng YT; Wang J; Hu Y; Wang YQ; Lin ZH
    J Biomol Struct Dyn; 2020 Sep; 38(15):4567-4578. PubMed ID: 31760877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA.
    Pirhadi S; Ghasemi JB
    Eur J Med Chem; 2010 Nov; 45(11):4897-903. PubMed ID: 20810190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SAR and QSAR studies: modelling of new DAPY derivatives.
    Thakur A; Thakur M; Bharadwaj A; Thakur S
    Eur J Med Chem; 2008 Mar; 43(3):471-7. PubMed ID: 17583387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.